Pfizer (PFE) stock, Alnylam (ALNY) stock and BridgeBio (BBIO) stock jump after a trial setback for an ATTE-CM drug from Astra ...

Eplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and ...

AstraZeneca stock crashed Thursday after its Ionis-partnered treatment for a rare heart disease failed in Phase 3 testing.

BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective ...

Shares in AstraZeneca were trading down more than 8% this morning after it revealed that its transthyretin amyloidosis (ATTR) ...

GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs ...

The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.

A Midtown high-rise that suffered structural damage was stable for now, New York City’s buildings commissioner said, but he warned of tense days ahead.

HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ('Lynk Pharmaceuticals'), a ...

Crews worked through the night to shore up a massive, under-construction apartment building in Manhattan after columns buckled and floors sagged, triggering widespread evacuations and street closures ...

Teva plans to start a Phase IIb study on TEV-‘408 in vitiligo during the final quarter of 2026.